Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.  [electronic resource] 

 -  JAMA oncology  10 2018 
 - e182078 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2374-2445 
<br/><br/><label>Standard No.: </label>10.1001/jamaoncol.2018.2078  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--blood<br/>CA-125 Antigen--blood<br/>Carcinoembryonic Antigen--blood<br/>Female<br/>Humans<br/>Keratin-19--blood<br/>Lung Neoplasms--blood<br/>Male<br/>Mass Screening--methods<br/>Membrane Proteins--blood<br/>Middle Aged<br/>Non-Smokers<br/>Prospective Studies<br/>Protein Precursors--blood<br/>Proteolipids--blood<br/>ROC Curve<br/>Risk Assessment--methods<br/>Risk Factors<br/>Tomography Scanners, X-Ray Computed